To evaluate the significance of
interleukin 4 (IL-4) in
tumor development, we compared B16F10
melanoma growth in IL-4-overespressing transgenic mice (IL-4 mice) and non-transgenic mice. In
IL-4 mice, reduced
tumor volume and weight were observed when compared with those of non-transgenic mice. Significant activation of
DNA binding activity of STAT6, phosphorylation of STAT6 as well as
IL-4, IL-4Rα and p21 expression were found in the
tumor tissues of
IL-4 mice compared to non-transgenic mice. Higher expression of
IL-4, STAT6 and p21 in human
melanoma tissue compared to normal human skin tissue was also found. Higher expression of apoptotic
protein such as cleaved
caspase-3, cleaved
caspase-8, cleaved
caspase-9, Bax, p53 and p21, but lower expression levels of survival
protein such as Bcl-2 were found in the
tumor of
IL-4 mice. In vitro study, we found that overexpression of
IL-4 significantly inhibited SK-MEL-28 human
melanoma cell and B16F10 murine
melanoma cell growth via p21-mediated activation of STAT6 pathway as well as increased expression of apoptotic cell death
proteins. Moreover, p21 knockdown with
siRNA abolished
IL-4 induced activation of STAT6 and expression of p53 and p21 accompanied with reduced
IL-4 expression as well as
melanoma cell growth inhibition. Therefore, these results showed that
IL-4 overexpression suppressed
tumor development through p21-mediated activation of STAT6 pathways in
melanoma models.